跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CETROTIDE cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe - TGA Drug Approval Details
Approvals
/
TGA
/
CETROTIDE cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe
Approved
STANDARD
CETROTIDE cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe
Merck Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
64629fa735c8951f
Company
Merck Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
64629fa735c8951f
Product Name
CETROTIDE cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe
Artg Id
74888
Artg Name
CETROTIDE cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe
Sponsor
Merck Healthcare Pty Ltd
Company Detail Path
/organization/merck-healthcare-pty-ltd
Artg Date
2000-12-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5055399602a4cca902fcbc7853cfb9cc.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/1b4f9d3861488956df903cc933b7810f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
64629fa735c8951f
Type
Standard
Back to TGA Approvals